Author

Ryo Takeuchi

ORCID 0009-0001-6491-0666Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Ryo Takeuchi1 paper · TScan Therapeutics (United States)

Biology Disciplines

Click to filter author papers

Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:DNA methylation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Amena ArifiD· 1 shared Jennifer GordoniD· 1 shared Samuel S. SlatteryiD· 1 shared Wenwen HuoiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

Amena ArifORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BioengineeringMolecular Therapy — Nucleic AcidsPeer-reviewedMay 1, 2026

Multiplex Gene Editing Suppresses Random Integration of Hepatitis B Virus DNA in Chronically Infected Liver

Samuel S. Slattery, Wenwen Huo, Amena Arif…·Ryo Takeuchi

This study uses CRISPR-Cas9 to reduce HBV DNA in infected cells, showing it suppresses random integration without affecting chromosomal translocations.

1 citation

𝕏 PostBluesky